Pulmozyme (Genentech, Inc.)


Welcome to the PulseAid listing for the Pulmozyme drug offered from Genentech, Inc.. This Decreased Respiratory Secretion Viscosity [PE],Deoxyribonuclease I [Chemical/Ingredient],Recombinant Human Deoxyribonuclease 1 [EPC],Recombinant Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: dornase alfa
SUBSTANCE NAME: DORNASE ALFA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Respiratory Secretion Viscosity [PE],Deoxyribonuclease I [Chemical/Ingredient],Recombinant Human Deoxyribonuclease 1 [EPC],Recombinant Proteins [Chemical/Ingredient]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1993-12-30
END MARKETING DATE: 0000-00-00


Pulmozyme HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPulmozyme from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 1993-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50242-100_e93b9176-2d17-4a2a-9b09-65ff6b6e21c6
PRODUCT NDC: 50242-100
APPLICATION NUMBER: BLA103532

Other DORNASE ALFA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.Pulmozyme